PathoQuest Announces Partnership with Charles River Laboratories

PathoQuest Announces Partnership with Charles River Laboratories


This preferred partnership agreement will provide Charles River customers access to PathoQuest's NGS-based testing solution, which can identify viral contaminants in biological products via a single comprehensive test, overcoming limitations of current viral safety testing methods. )--PathoQuest, a rapidly growing biotechnology company spun out from Institut Pasteur, today announced a preferred partnership with Charles River Laboratories, an early-stage contract research organization , to provide an improved Viral Safety Service offering to biopharmaceutical companies.



from Biotech News